🔎 Trials Near Me

Home › High Blood Pressure › California › San Diego

High Blood Pressure clinical trials in San Diego, CA

5 studies for High Blood Pressure are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

RecruitingPhase 3
  • Acclaim Clinical Research, San Diego
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

RecruitingPhase 3
  • Clinical Trial Site, San Diego
  • Clinical Trial Site, La Jolla · 11 mi away
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

Recruiting
  • University of California, San Diego, La Jolla · 11 mi away
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07725250

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

Recruiting
  • Family Health Centers of San Diego, San Diego
Ages 21 and older · All sexes · Updated Feb 9, 2026 · NCT07398391

Multi-Omics for Maternal Health After Preeclampsia

RecruitingObservational studyHealthy volunteers welcome
  • University of California, San Diego, San Diego
Ages 18 to 50 · Women · Updated Apr 6, 2025 · NCT06340152

About High Blood Pressure

High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.

More about High Blood Pressure on MedlinePlus

High Blood Pressure trials in other cities

Other studies in San Diego

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.